Validity of the King Devick Test for Acute Diagnosis of Concussion in NCAA Division I Athletes

金-德维克测试在NCAA一级运动员急性脑震荡诊断中的有效性

阅读:1

Abstract

BACKGROUND: The King-Devick (KD) test is a timed rapid number naming test used for the acute diagnosis of concussion. HYPOTHESIS: The KD test will be more sensitive, but less specific, than other commonly used objective tests for concussion. STUDY DESIGN: Case-control study. LEVEL OF EVIDENCE: Level 4. METHODS: National Collegiate Athletic Association Division I college athletes completed baseline testing for the KD. When an athlete presented acutely with suspected concussion from July 1, 2020 to December 31, 2022 (sideline/within 48 hours) the test was repeated. If a concussion was diagnosed, a control matched on comorbid conditions, sex/gender, team, season, and baseline test time was identified to test. RESULTS: Baseline and postinjury data were collected for 97 concussed and 97 matched control athletes. In total, 44% of concussions occurred in female athletes, with most concussion occurring in football 37 (38%), women's volleyball 14 (14%), and softball 6 (6%). The KD test had fair test-retest reliability at 0.72 (95% CI, 0.61-0.80). The sensitivity and specificity of the test for any increase in time compared with baseline was 81% and 56%, with a positive predictive value of 65% and negative predictive value of 75%. The AUC was also fair at 0.75 (0.68-0.82). There was no significant difference in accuracy of the KD taken at different times points (immediate, 2-8 hours, 8-24 hours, 24-48 hours). CONCLUSION: The KD is more sensitive, but less specific, than other commonly used objective tests for concussion. Understanding the psychometric properties of the KD can help with the diagnosis of concussion. CLINICAL RELEVANCE: The KD may be a good initial screening tool to prompt further evaluation or allow return to play without further evaluation. Further study in other populations is needed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。